COVID-19 Vaccine

 Eligibility

Pfizer-BioNTech

1st Dose

For: Ages 6 months+

2nd Dose

For: Ages 6 months+ | 21 days after 1st Dose

3rd Dose

For: Ages 6 months – 4 years | 56 days after 2nd Dose
For: Immunocompromised (ages 5+) | 28 days after 2nd Dose

Booster (Bivalent)

For: Ages 6 months -  4 years who have not yet begun their three-dose primary series of the Pfizer-BioNTech COVID-19 Vaccine or have not yet received the third dose of their primary series will now receive the updated (bivalent) Pfizer-BioNTech COVID-19 vaccine as the third dose in their primary series following two doses of the original (monovalent) Pfizer-BioNTech COVID-19 Vaccine.

For: Ages 5+ | 2 months after completion of COVID-19 vaccine primary series or previous booster 

Moderna

1st Dose

For: Ages 6 months+

2nd Dose

For: Age 6 months+ | 28 days after 1st Dose

3rd Dose

For: Immunocompromised (ages 6 months+) | 28 days after 2nd Dose

Booster (Bivalent)

For: Ages 6 months - 5 years | 2 months after completion of COVID-19 vaccine primary series

For: Ages 6+ | 2 months after completion of COVID-19 vaccine primary series or previous booster

Novavax*

1st Dose

For: Ages 12+

2nd Dose

For: Age 12+ | 21 days after 1st Dose

Booster 

For: Ages 18 years and older | 6 months after completion of COVID-19 vaccine primary series


*mRNA vaccines are preferred, but the Novavax COVID-19 vaccine may be considered in some situations.